Found 18 matching trials
Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome PHASE2 The purpose of this randomized, double-blind, placebo-controlled study is t...
Show More Location
Southern Cancer Center
Learn More & Join Trial
A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms PHASE1 The purpose of Part 1 (Dose Escalation) of the study is to assess the effec...
Show More Learn More & Join Trial
Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy PHASE2 This phase II trial studies how well sirolimus and azacitidine works in tre...
Show More Location
Jefferson Health NJ Division (Kennedy Hospital)
Learn More & Join Trial
Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes PHASE2 RATIONALE: Drugs used in chemotherapy, such as azacitidine, work in differe...
Show More Location
Wake Forest University Comprehensive Cancer Center
Learn More & Join Trial
Study Evaluating Venetoclax in Subjects With Hematological Malignancies PHASE1 This study is evaluating the safety, pharmacokinetic profile and efficacy o...
Show More Location
NHO Nagoya Medical Center /ID# 129222
Learn More & Join Trial
Venetoclax to Augment Epigenetic Modification and Chemotherapy PHASE1 The investigator is testing the addition of venetoclax to 5-azacitidine and...
Show More Location
Children's Wisconsin
Learn More & Join Trial
Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA PHASE2 The purpose of this open label study is to determine whether combining prac...
Show More Location
Southern Cancer Center
Learn More & Join Trial
Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients PHASE2 This is a multicenter, nonrandomized, open-label phase 2 study (with a safe...
Show More Location
Johns Hopkins Oncology Center
Learn More & Join Trial
Window Trial 5-aza in HNSCC, T-tare PHASE1 The purpose of this study is to assess the activity of 5-azacitidine in pat...
Show More Location
Smilow Cancer Center at Yale New Haven Hospital
Learn More & Join Trial
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia PHASE2 This phase II trial studies how well azacitidine and venetoclax with or wit...
Show More Status
Active Not Recruiting
Location
Smilow Cancer Hospital Care Center at Greenwich
Learn More & Join Trial